About Contact Us Careers
Sign In

Neurostimulator Device Market Analysis by Product (Spinal Cord Stimulators, Vagus Nerve Stimulators, Deep Brain Stimulators, Sacral Nerve Stimulators, and Others), by End-User (Hospitals, Specialty Clinics, and Others), and by Application (Pain Management, Hearing Loss, Urinary Incontinence, Parkinson's Disease, Epilepsy, and Others) – Global Supply & Demand Analysis & Opportunity Outlook 2023-2035

  • Report ID: 3233
  • Published Date: Mar 01, 2023
  • Report Format: PDF, PPT

Companies Dominating the Neurostimulator Device Landscape

top-features-companies

    • Boston Scientific Corporation

      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Medtronic PLC
    • Abbott Laboratories
    • Nevro Corp.
    • Liva Nova PLC
    • Axonics Modulation Technologies Inc.
    • Neuropace Inc.
    • EndoStimInc.
    • NDI Medical
    • Cochlear Limited
    • Neuronetics Inc.
Browse Key Market Insights with Data Illustration:

In the News

  •  Medtronic PLC introduced the Medtronic Neurovascular Co-Lab Platform, which will eventually progress technological ideas with the greatest potential to benefit millions of stroke patients. Further, this platform will aid in the realization of neurovascular innovations.

  • Boston Scientific Corporation announced STIMVIEW XT, its most recent image guided programming software, has been approved by the U.S. Food and Drug Administration (FDA). The software provides real-time visualization of lead placement and stimulation modelling of the brain architecture of individuals with Parkinson's disease or essential tremor for physicians.


Author Credits:  Radhika Gupta, Shivam Bhutani


  • Report ID: 3233
  • Published Date: Mar 01, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Increasing elderly population and the rising prevalence of neurological disorders are the major factors driving the market growth.

The market is anticipated to attain a CAGR of 14% over the forecast period, i.e., 2023-2035.

Exorbitant cost of neurostimulator equipments, and existence of other treatment options, such as drug therapies and surgeries are estimated to be the growth hindering factors for the market expansion.

The market in the North American region is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.

The major players in the market are Medtronic PLC, Abbott Laboratories, Nevro Corp., Liva Nova PLC, Axonics Modulation Technologies Inc., Neuropace Inc., EndoStimInc., NDI Medical, Cochlear Limited, Neuronetics Inc., and others.

The company profiles are selected on the basis of revenues generated from the product segment, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.

The market is segmented by application, product, end user, and by region.

The spinal cord stimulator segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.
Inquiry Before Buying Request Free Sample

Copyright © 2024 Research Nester. All Rights Reserved

logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying